These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24781934)

  • 21. [Exploration of hemostasis in current practice].
    Aiach M; Gaussem P
    Ann Pharm Fr; 1996; 54(1):21-4. PubMed ID: 8702189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A practical concept for preoperative identification of patients with impaired primary hemostasis.
    Koscielny J; Ziemer S; Radtke H; Schmutzler M; Pruss A; Sinha P; Salama A; Kiesewetter H; Latza R
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):195-204. PubMed ID: 15247976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory diagnosis of bleeding disorders. Basic screening tests.
    Palmer RL
    Postgrad Med; 1984 Dec; 76(8):137-42, 147-8. PubMed ID: 6334288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer.
    Shetty S; Ghosh K; Mohanty D
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):493-7. PubMed ID: 12851537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reagent-dependent pseudo-prolongation of activated partial thromboplastin time].
    Miyazaki S; Nishida Y; Asagiri T; Shigetome K; Kida K; Hisakawa H; Togitani K; Kojima K
    Rinsho Ketsueki; 2021; 62(10):1515-1518. PubMed ID: 34732626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of Routine Coagulation Tests in Healthy Children Undergoing Elective Minor Surgery: a 12-Year Retrospective Study.
    Song J; Jung HW; Lee EH; Chang HK; Yoon HS
    Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of clotting screens.
    Thorell SE; Nash MJ; Thachil J
    Int J Lab Hematol; 2015 Feb; 37(1):8-13. PubMed ID: 24636194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a chromogenic prothrombin time with clotting prothrombin time in the assessment of clinical coagulation deficiencies.
    Francis CW; Malone JE; Marder VJ
    Am J Clin Pathol; 1985 Dec; 84(6):724-9. PubMed ID: 4072967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions.
    Barna L; Triplett DA
    Ric Clin Lab; 1989; 19(4):345-54. PubMed ID: 2517350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.
    Park KJ; Kwon EH; Ma Y; Park IA; Kim SW; Kim SH; Kim HJ
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):35-8. PubMed ID: 22027757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats].
    Deniz A; Mischke R; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):206-8. PubMed ID: 8593777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of Activated Partial Thromboplastin Time (APTT): Determining Reagent Sensitivity to Factor Deficiencies, Heparin, and Lupus Anticoagulants.
    Kershaw G
    Methods Mol Biol; 2017; 1646():75-83. PubMed ID: 28804819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and performance characteristics of the Q Hemostasis Analyzer, an automated coagulation analyzer.
    Toulon P; Fischer F; Appert-Flory A; Jambou D
    Thromb Res; 2014 May; 133(5):927-35. PubMed ID: 24650798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thrombinography: towards a globalization of coagulation tests].
    Péters P; Gothot A
    Rev Med Liege; 2009 Apr; 64(4):199-203. PubMed ID: 19514539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy.
    Cugno M; Gualtierotti R; Tedeschi A; Meroni PL
    Autoimmun Rev; 2014 Jan; 13(1):40-8. PubMed ID: 23954454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis.
    van Herrewegen F; Meijers JC; Peters M; van Ommen CH
    Eur J Pediatr; 2012 Feb; 171(2):207-14. PubMed ID: 21922352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.